BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6304228)

  • 1. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.
    Sewell WA; Munoz JJ; Vadas MA
    J Exp Med; 1983 Jun; 157(6):2087-96. PubMed ID: 6304228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.
    Sewell WA; de Moerloose PA; McKimm-Breschkin JL; Vadas MA
    Cell Immunol; 1986 Feb; 97(2):238-47. PubMed ID: 3091271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of experimental allergic encephalomyelitis in mice with the aid of pertussigen from Bordetella pertussis.
    Munoz JJ; Mackay IR
    Cell Immunol; 1984 Jul; 86(2):541-5. PubMed ID: 6329525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pertussigen on inflammation caused by Freund adjuvant.
    Munoz JJ; Sewell WA
    Infect Immun; 1984 Jun; 44(3):637-41. PubMed ID: 6539301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity induced by anti-T-cell-line antisera is enhanced by pertussigen and not restricted by histocompatibility genes.
    Gamble JR; Vadas MA; Munoz JJ; Thomas WR; Miller JF
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2036-9. PubMed ID: 6300889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pertussis toxin (PT) on T-cell populations sensitized for delayed-type hypersensitivity in mice.
    Tamura SI; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1984 May; 85(2):351-63. PubMed ID: 6609000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pertussis toxin on delayed-type hypersensitivity responses and on the activity of suppressor T cells on the responses.
    Tamura S; Nakanishi Y; Kojima A; Otokawa M; Uchida N; Sato H; Sato Y
    Cell Immunol; 1983 Oct; 81(2):219-28. PubMed ID: 6315242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
    Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
    Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen.
    Jacysyn JF; Abrahamsohn IA; Macedo MS
    Immunology; 2001 Mar; 102(3):373-9. PubMed ID: 11298838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen.
    Munoz JJ; Bernard CC; Mackay IR
    Cell Immunol; 1984 Jan; 83(1):92-100. PubMed ID: 6607126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of genetically susceptible mice against chronic infection with Nematospiroides dubius using pertussigen as adjuvant.
    Mitchell GF; Munoz JJ
    Aust J Exp Biol Med Sci; 1983 Aug; 61 (Pt 4)():425-34. PubMed ID: 6316887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.
    Munoz JJ; Arai H; Cole RL
    Infect Immun; 1981 Apr; 32(1):243-50. PubMed ID: 6260681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Bordetella pertussis components on IgE and IgG1 responses.
    Sekiya K
    Microbiol Immunol; 1983; 27(11):905-15. PubMed ID: 6321910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussigen in vivo enhances antigen-specific production in vitro of lymphokine that stimulates macrophage procoagulant activity and plasminogen activator.
    de Moerloose PA; Hamilton JA; Sewell WA; Vadas MA; Mackay IR
    J Immunol; 1986 Dec; 137(11):3528-33. PubMed ID: 3782790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of delayed-type hypersensitivity reactions to ovalbumin by cyclophosphamide in the mouse: strain variability, antigen specificity and nature of the suppressor cell.
    Thomson AW; Nelson DS; Moon DK
    Ann Immunol (Paris); 1983; 134D(3):267-75. PubMed ID: 6202228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.